Cumberland Pharmaceuticals Income Statement (2010-2026) | CPIX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	9.06M	8.07M	8.32M	11.18M	10.30M	11.41M	9.12M	9.22M	10.89M	10.09M	9.35M	8.50M	9.85M	9.09M	10.44M	11.71M	10.84M	8.29M	13.68M	9.13M
Cost of Revenue (Quarter)	1.74M	1.33M	3.31M	2.21M	4.56M	4.11M	10.19M	4.28M	4.67M	1.77M	1.53M	4.15M	1.71M	1.32M	-6.21M	4.23M	2.01M	4.43M	-6.22M	1.93M
Gross Profit (Quarter)	7.31M	6.74M	5.01M	8.96M	5.74M	7.30M	-1.07M	4.95M	6.22M	8.32M	7.82M	4.34M	8.14M	7.76M	16.65M	7.48M	8.83M	3.86M	19.90M	7.20M
Operating items
Amortization - Intangibles (Quarter)	1.17M	1.01M	1.02M	1.59M	1.53M	1.49M	0.46M	1.23M	1.16M	1.18M	4.54M	1.11M	1.10M	1.08M	1.46M	1.01M	1.01M	1.01M	1.01M	1.25M
Research & Development (Quarter)	1.36M	1.45M	1.61M	1.75M	1.82M	1.71M	1.41M	1.50M	1.15M	1.92M	1.26M	1.16M	1.06M	1.31M	1.29M	1.30M	1.47M	1.25M	1.55M	1.46M
Selling, General & Administrative (Quarter)	2.10M	2.04M	3.41M	2.30M	2.20M	2.17M	3.51M	2.50M	2.37M	2.34M	3.44M	2.37M	2.76M	2.68M	3.33M	2.46M	2.87M	2.57M	4.04M	2.55M
Other Operating Expenses (Quarter)	7.03M	6.14M	7.65M	8.42M	8.12M	7.82M	6.49M	6.76M	7.35M	7.68M	10.83M	6.84M	7.06M	6.80M	7.66M	6.66M	7.24M	6.43M	9.46M	8.25M
Operating Expenses (Quarter)	10.49M	9.64M	12.67M	12.47M	12.15M	11.70M	11.40M	10.76M	10.87M	11.95M	15.53M	10.37M	10.88M	10.78M	12.28M	10.42M	11.58M	10.26M	15.05M	12.26M
Operating Income (Quarter)	-1.44M	-1.56M	-4.35M	-1.29M	-1.85M	-0.29M	-2.28M	-1.53M	0.02M	-1.87M	-6.18M	-1.87M	-1.03M	-1.69M	-1.84M	1.29M	-0.75M	-1.97M	-1.37M	-3.13M
EBIT (Quarter)	-1.44M	-1.56M	-4.35M	-1.29M	-1.85M	-0.29M	-2.28M	-1.53M	0.02M	-1.87M	-6.18M	-1.87M	-1.03M	-1.69M	-1.84M	1.29M	-0.75M	-1.97M	-1.37M	-3.13M
Non-operating items
Interest & Investment Income (Quarter)	0.01M	0.01M	0.01M	0.02M	0.02M	0.02M	0.05M	0.05M	0.06M	0.10M	0.08M	0.10M	0.06M	0.07M	0.11M	0.13M	0.13M	0.13M	0.09M	0.08M
Net income details
EBT (Quarter)	0.73M	-1.58M	-4.38M	-1.40M	-1.36M	-0.42M	-2.41M	0.18M	0.87M	-1.06M	-6.28M	-1.89M	-1.09M	-1.53M	-1.96M	1.25M	-0.73M	-1.94M	-1.39M	-3.14M
Tax Provisions (Quarter)	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.05M	0.01M	0.01M	0.01M	0.02M	0.01M	0.01M	0.01M	-0.06M	0.01M	0.01M	0.01M	0.02M	0.00M
Profit After Tax (Quarter)	0.72M	-1.06M	-3.85M	-1.39M	-1.34M	-0.41M	-2.46M	0.17M	0.87M	-1.05M	-6.30M	-1.90M	-1.09M	-1.54M	-1.90M	1.26M	-0.74M	-1.95M	-1.41M	-3.29M
Equity Income (Quarter)																				-0.15M
Net Income - Minority (Quarter)	0.14M														0.31M				0.34M	0.33M
Income from Non-Controlling Interests (Quarter)	-0.01M	-0.03M	-0.04M	-0.02M	-0.03M	-0.01M	-0.02M	-0.02M	-0.01M	-0.01M	-0.01M	0.04M	-0.02M	0.01M	0.00M	-0.01M	0.01M	-0.01M	-0.02M	0.00M
Income from Continuing Operations (Quarter)	0.72M	-1.58M	-4.39M	-1.40M	-1.36M	-0.42M	-2.46M	0.17M	0.86M	-1.06M	-6.30M	-1.90M	-1.10M	-1.54M	-1.90M	1.25M	-0.74M	-1.95M	-1.42M	-3.14M
Consolidated Net Income (Quarter)	0.50M	0.50M	0.50M					0.17M	0.86M	-1.06M	-6.30M	-1.90M	-1.10M	-1.54M	-1.90M	1.25M	-0.74M	-1.95M	-1.42M	-3.14M
Income towards Parent Company (Quarter)	0.64M	0.50M	0.50M					0.17M	0.86M	-1.06M	-6.30M	-1.90M	-1.10M	-1.54M	-1.59M	1.25M	-0.74M	-1.95M	-1.08M	-2.81M
Net Income towards Common Stockholders (Quarter)	0.64M	0.50M	0.50M					0.17M	0.86M	-1.06M	-6.30M	-1.90M	-1.10M	-1.54M	-1.59M	1.25M	-0.74M	-1.95M	-1.08M	-2.81M
Additional items
EPS (Basic) (Quarter)	0.08	-0.07	-0.29	-0.09	-0.09	-0.03	-0.17	0.01	0.06	-0.07	-0.44	-0.14	-0.08	-0.11	-0.14	0.08	-0.05	-0.13	-0.09	-0.22
EPS (Weighted Average and Diluted) (Quarter)	0.05	-0.10	-0.29	-0.09	-0.09	-0.03	-0.17	0.01	0.06	-0.07	-0.44	-0.14	-0.08	-0.11	-0.14	0.08	-0.05	-0.13	-0.09	-0.22
Shares Outstanding (Weighted Average) (Quarter)	14.97M	14.88M	14.90M	14.69M	14.69M	14.48M	14.56M	14.36M	14.39M	14.28M	14.30M	14.10M	14.12M	14.09M	14.06M	14.94M	14.96M	14.95M	14.85M	14.96M
Shares Outstanding (Diluted Average) (Quarter)	15.11M	15.14M	14.90M	14.69M	14.69M	14.48M	14.56M	14.59M	14.55M	14.28M	14.30M	14.10M	14.11M	14.05M	14.06M	15.26M	14.96M	14.95M	14.85M	14.96M
EBITDA (Quarter)	-1.44M	-1.56M	-4.35M	-1.29M	-1.85M	-0.29M	-2.28M	-1.53M	0.02M	-1.87M	-6.18M	-1.87M	-1.03M	-1.69M	-1.84M	1.29M	-0.75M	-1.97M	-1.37M	-3.13M
Interest Expenses (Quarter)	0.03M	0.02M	0.03M	0.12M	0.14M	0.15M	0.18M	0.19M	0.19M	0.11M	0.18M	0.12M	0.13M	0.14M	0.22M	0.16M	0.11M	0.11M	0.11M	0.09M
Tax Rate (Quarter)	1.02%	-0.47%	-0.29%	-0.49%	-0.51%	-1.66%	-2.00%	3.87%	0.80%	-0.66%	-0.40%	-0.61%	-1.05%	-0.75%	2.91%	0.45%	-0.78%	-0.29%	-1.65%	-0.12%

Research Tools

Cumberland Pharmaceuticals Income Statement (2010-2026) | CPIX

Create an account

Sign In

Reset Password